SCHEMBL24810232

SCHEMBL24810232

CC(C)C(O)N1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20905549 0.94 SMN1; SMN2 (0.35)
SCHEMBL24264704 0.92 SMN1; SMN2 (0.38)
SCHEMBL10194420 0.80 CHRNA7 (0.39)
SCHEMBL18526726 0.78 SMN1; SMN2 (0.33)
SCHEMBL10194414 0.78 MC4R (0.39)
SCHEMBL486195 0.77 SMN1; SMN2 (0.35)
SCHEMBL18897006 0.76 KCNA5 (0.41)
SCHEMBL23547193 0.76 SMN1; SMN2 (0.36)
SCHEMBL5779140 0.76 SMN1; SMN2 (0.36)
SCHEMBL5746901 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411429-A1 CONDENSED PYRIDAZINE OR PYRIMIDINE AS BTK INHIBITORS BIOGEN MA INC. 2022-12-29 US disclosed